modipafant has been researched along with Lung Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, S; Pinho, V; Shimizu, T; Soares, AC; Souza, DG; Teixeira, MM | 1 |
| Arantes, EC; Coelho, AM; Coelho, FM; Pessini, AC; Pinho, VS; Souza, DG; Teixeira, AL; Teixeira, MM | 1 |
2 other study(ies) available for modipafant and Lung Diseases
| Article | Year |
|---|---|
Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment.
Topics: Animals; Dihydropyridines; Disease Models, Animal; Imidazoles; Intestinal Diseases; Intestines; Lung Diseases; Male; Mesenteric Artery, Superior; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Reperfusion Injury | 2003 |
Platelet activating factor receptors drive CXC chemokine production, neutrophil influx and edema formation in the lungs of mice injected with Tityus serrulatus venom.
Topics: Animals; Chemokines, CXC; Dihydropyridines; Dose-Response Relationship, Drug; Edema; Granulocyte Colony-Stimulating Factor; Imidazoles; Interleukin-3; Lung Diseases; Male; Mice; Neutrophils; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Recombinant Proteins; Scorpion Venoms; Scorpions; Sulfonamides; Time Factors | 2007 |